| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anixa Biosciences, Inc. (ANIX) has 5 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. ANIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 987.0K | $3.65M | +14.8K | |
| CEO | 640.8K | $2.37M | +10.0K | |
| CFO | 175.0K | $647.5K | - | |
| Dir | 135.0K | $499.5K | - | |
| Dir | 25.0K | $92.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2020 | Kumar Amit62 | Chief Executive Officer | Buy | 28,000 | $2.11 | $59,080.00 | +12.0% | |
| Jun 16, 2020 | Titterton Lewis H Jr65 | Director | Buy | 24,500 | $2.27 | $55,615.00 | +2.6% | |
| Jun 15, 2020 | Titterton Lewis H Jr65 | Director | Buy | 31,083 | $2.27 | $70,558.41 | +3.4% | |
| Jun 12, 2020 | Kumar Amit62 | Chief Executive Officer | Buy | 20,000 | $2.03 | $40,600.00 | +9.3% | |
| Mar 13, 2020 | Titterton Lewis H Jr65 | Director | Buy | 5,799 | $2.12 | $12,293.88 | +0.6% | |
| Mar 12, 2020 | Kumar Amit62 | Chief Executive Officer | Buy | 20,000 | $1.82 | $36,400.00 | +10.3% | |
| Mar 12, 2020 | Baskies Arnold M48 | Director | Buy | 10,000 | $1.84 | $18,400.00 | +32.3% | |
| Mar 6, 2020 | Baskies Arnold M48 | Director | Buy | 10,000 | $2.71 | $27,100.00 | +47.6% | |
| Jan 17, 2020 | Baskies Arnold M48 | Director | Buy | 10,000 | $3.53 | $35,300.00 | +90.9% | |
| Jan 15, 2020 | Titterton Lewis H Jr65 | Director | Buy | 5,000 | $3.32 | $16,600.00 | +0.5% |